Structural Mechanism of Mammalian Prion Infectivity
Structural Mechanism of Mammalian Prion Infectivity
批准号:
10610392
负责人:
Surachai Supattapone
金额:
$53.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-15 至 2025-04-30
关键词:
Alzheimer&aposs DiseaseAmino AcidsAnimalsBiochemicalBiologicalBovine Spongiform EncephalopathyChemicalsCouplingCreutzfeldt-Jakob SyndromeDataDevelopmentDiagnosticDigestionDissociationElectron MicroscopyElementsEndopeptidase KGoalsHumanIn VitroInfectious AgentIsotope LabelingIsotopesLaboratoriesLinkLivestockMaintenanceMapsMass Spectrum AnalysisMeasurementMembrane LipidsMethodsModelingMolecularMolecular ConformationMolecular StructureNeurodegenerative DisordersNuclear Magnetic ResonanceParkinson DiseasePathogenesisPatternPhosphatidylethanolaminePositioning AttributePrPPrion DiseasesPrionsProcessPropertyProtein SubunitsProteinsRecombinantsRegistriesResearchResolutionRoleSamplingShapesSideStructural ModelsStructureSystemTechniquesTimeVaccinesVariantVertebral columnVisualizationWild Type MouseWorkbeta pleated sheetcofactorconformerdiagnostic toolexperimental studynervous system disordernovelpathogenic isoformprotein misfoldingprotein protein interactionprotein structurepublic health relevancerecombinant PrPsolid state nuclear magnetic resonance
中文摘要
项目摘要
哺乳动物的Prion,它会导致人和牲畜的致命神经退行性疾病
动物是一种非正统的感染体,通过自身催化构象进行复制
将宿主蛋白(PrPC)转变为致病异构体(PrPSc)。接受一个简化论者
生化方法,我们有一个令人惊讶的发现,内源性辅助因子,如
膜脂磷脂酰乙醇胺(PE)是产生感染性PrPSc所必需的
分子。例如,自催化PrPSc分子由以下物质组合形成
重组PrP和PE底物显示出比
由PrP单独生成类似的自催化PrPSc分子。我们已经利用了
这一特定信息第一次产生了足够数量的充分
传染性的、同位素标记的和构象均一的重组普鲁恩
进行PrPSc结构的高分辨固体(Ss)核磁共振分析。在这里,我们的
合作团队建议使用单核磁共振、电子显微镜和质谱学
分析以阐明导致传染性的重要结构要素。SS核磁共振将是
用于确定和比较感染性和非感染性的二级结构图
PrPSc分子。这项工作将有助于识别和表征与特定传染性相关的
结构域以及关键的核磁共振残基峰归属。以及来自以下方面的约束
用电子显微镜和质谱仪分析确定切割点的位置
被K酶消化,这些数据最终将使整个结构的确定成为可能
PrPSc分子。我们还将使用ss核磁共振通过以下方式精确确定结构机理
哪种PE诱导具有感染性的朊病毒构象。最后,我们将使用15N-13C转移-
回声双共振(TEDOR)确定PrPSc亚基的对称性
具有感染性的重组普恩病毒的同位素混合样本。这些数据将使我们能够
竞争的b-螺线管和寄存器内b-薄片四元结构模型的区分
具有传染性的PrPSc分子。总体而言,这项提议是朝着确定
感染性哺乳动物朊病毒的全高分辨结构测定
作为普恩病毒感染性的结构机制。
英文摘要
Project Summary
Mammalian prions, which cause fatal neurodegenerative diseases in humans and livestock
animals, are unorthodox infectious agents that replicate by the autocatalytic conformational
change of the host prion protein (PrPC) into a pathogenic isoform (PrPSc). Taking a reductionist
biochemical approach, we made the surprising discovery that endogenous cofactors such as
the membrane lipid phosphatidylethanolamine (PE) are required to produce infectious PrPSc
molecules. For example, autocatalytic PrPSc molecules formed with a combination of
recombinant PrP and PE substrates display a specific infectivity >105-fold greater than that of
similar autocatalytic PrPSc molecules formed from PrP alone. We have taken advantage of
this specific information to produce, for the first time, sufficient quantities of fully
infectious, isotopically labeled, and conformationally homogeneous recombinant prions
to perform high-resolution solid state (ss) NMR analysis of PrPSc structure. Here, our
collaborative team proposes to use ssNMR, electron microscopy, and mass spectrometry
analysis to elucidate the important structural elements that lead to infectivity. ssNMR will be
used to determine and compare the secondary structure maps of infectious and non-infectious
PrPSc molecules. This work will help identify and characterize specific infectivity-associated
domains as well as crucial NMR residue-peak assignments. Together with constraints from
electron microscopy and mass spectrometry analysis to identify the position of cut points using
digestion by proteinase K, these data will eventually enable structural determination of the entire
PrPSc molecule. We will also use ssNMR to determine precisely the structural mechanism by
which PE induces the infectious prion conformation. Finally, we will use 15N-13C transferred-
echo double resonance (TEDOR) to determine the symmetry pattern of PrPSc subunits in
isotopically mixed samples of infectious recombinant prions. These data will allow us to
discriminate between competing b-solenoid and in-register b-sheet quaternary structure models
of infectious PrPSc molecules. Overall, this proposal is a critical step towards determining
the full high-resolution structural determination of infectious mammalian prions as well
as the structural mechanism of prion infectivity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mapping molecular pathways that control prion metabolism
-
批准号:10539945
-
项目类别:
-
资助金额:$68.66万
-
财政年份:2022
-
负责人:Surachai Supattapone
-
依托单位:
Mapping Molecular Pathways that Control Prion Metabolism
-
批准号:10670437
-
项目类别:
-
资助金额:$67.84万
-
财政年份:2022
-
负责人:Surachai Supattapone
-
依托单位:
Structural Mechanism of Mammalian Prion Infectivity
-
批准号:10191067
-
项目类别:
-
资助金额:$59.69万
-
财政年份:2020
-
负责人:Surachai Supattapone
-
依托单位:
Novel therapeutic strategies targeting malleability of wild-type and mutant prions
-
批准号:10015750
-
项目类别:
-
资助金额:$47.25万
-
财政年份:2020
-
负责人:Surachai Supattapone
-
依托单位:
Novel therapeutic strategies targeting malleability of wild-type and mutant prions
-
批准号:10373098
-
项目类别:
-
资助金额:$48.19万
-
财政年份:2020
-
负责人:Surachai Supattapone
-
依托单位:
Novel Therapeutic Strategies Targeting Malleability of Wild-Type and Mutant Prions
-
批准号:10579944
-
项目类别:
-
资助金额:$52.61万
-
财政年份:2020
-
负责人:Surachai Supattapone
-
依托单位:
Structural Mechanism of Mammalian Prion Infectivity
-
批准号:10386899
-
项目类别:
-
资助金额:$53.92万
-
财政年份:2020
-
负责人:Surachai Supattapone
-
依托单位:
Novel therapeutic strategies targeting malleability of wild-type and mutant prions
-
批准号:10191066
-
项目类别:
-
资助金额:$53.02万
-
财政年份:2020
-
负责人:Surachai Supattapone
-
依托单位:
Dissecting the Mechanism of Prion Formation with a Permissive Host
-
批准号:9910466
-
项目类别:
-
资助金额:$55.38万
-
财政年份:2018
-
负责人:Surachai Supattapone
-
依托单位:
Dissecting the Mechanism of Prion Formation with a Permissive Host
-
批准号:9512261
-
项目类别:
-
资助金额:$52.11万
-
财政年份:2017
-
负责人:Surachai Supattapone
-
依托单位:
Structural Mechanism of Mammalian Prion Infectivity
-
批准号:9512277
-
项目类别:
-
资助金额:$56.7万
-
财政年份:2017
-
负责人:Surachai Supattapone
-
依托单位:
Long-Term Safety, Efficacy, and Mechanism of PERK Inhibition Therapy for Prion Disease
-
批准号:9268578
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2016
-
负责人:Surachai Supattapone
-
依托单位:
Biochemistry of Infectious Prions
-
批准号:7765491
-
项目类别:
-
资助金额:$27.7万
-
财政年份:2007
-
负责人:Surachai Supattapone
-
依托单位:
Biochemistry of Infectious Prions
-
批准号:7361343
-
项目类别:
-
资助金额:$27.98万
-
财政年份:2007
-
负责人:Surachai Supattapone
-
依托单位:
Biochemistry of Infectious Prions
-
批准号:7250748
-
项目类别:
-
资助金额:$27.98万
-
财政年份:2007
-
负责人:Surachai Supattapone
-
依托单位:
Biochemistry of Infectious Prions
-
批准号:8033775
-
项目类别:
-
资助金额:$27.42万
-
财政年份:2007
-
负责人:Surachai Supattapone
-
依托单位:
Biochemistry of Infectious Prions
-
批准号:7579122
-
项目类别:
-
资助金额:$27.98万
-
财政年份:2007
-
负责人:Surachai Supattapone
-
依托单位:
Species Susceptibility Assay for Chronic Wasting Disease
-
批准号:7105317
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2004
-
负责人:Surachai Supattapone
-
依托单位:
Origin and Mechanism of Promiscuous Prion Strains
-
批准号:8625835
-
项目类别:
-
资助金额:$41.83万
-
财政年份:2004
-
负责人:Surachai Supattapone
-
依托单位:
Mechanism of Prion Neurotropism
-
批准号:7807081
-
项目类别:
-
资助金额:$31.17万
-
财政年份:2004
-
负责人:Surachai Supattapone
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: